Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020. Despite the continuing global uncertainty caused by the coronavirus and ongoing lockdowns around the world, 14 Yissum spinouts raised tens of millions...
New treatment, which allows previously topical drug to be administered intravenously, is ‘a game-changer’ in the battle against antibiotic-resistant bacteria. It could have a significant impact on the morbidity rate for pandemics such as...
The IIA awarded over 40% of its academic grants to HU reseachers exploring methods to combat the COVID-19 virus.
Under the collaboration, Cytovia will sponsor a research program for the development of multi-specific antibodies targeting both NK cells and the tumor antigen. The research will be led by Prof. Ofer Mandelboim from the Lautenberg Center for...
Dr. Goldwaser has been with Yissum since 2010, most recently serving as its SVP of Business Development & Alliance Management
190 Research Institutions from 29 Countries will Share Best Practices and Debate State of Academia-Industry Collaboration
The publication of ITTN's 2018 annual report shows the collective impact of the Technology Transfer sector in Israel. In 2018, Israeli tech transfer organizations (TTOs) evaluated 1,000 new innovations and filed over 620 new patents. In 2018,...
May 1, 2019 – Jerusalem – Yissum, the technology transfer company of The Hebrew University of Jerusalem, is hosting a first-of-its kind conference to drive academic-industry collaboration across multiple cannabis-related research and development...
January 23, 2019 – Jerusalem – Yissum, the Technology Transfer Company of the Hebrew University, announced today the opening of three centers of international cooperation in Chicago (United States), Asunción (Paraguay) and Shenzhen (China) to...
December 27th, 2018, Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem and KYORIN Pharmaceutical Co., Ltd. (Tokyo, Japan), a subsidiary of KYORIN Holdings, Inc., which is engaged in the development and...
December 11, 2018 – Jerusalem: The first ever commercial conference in Israel dedicated to the future of quantum technology is taking place today in Jerusalem. The event, on December 11, 2018 at The Hebrew University of Jerusalem, Edmond Safra...
Yissum is proud to announce a new novel technology for the 3D printing of drug capsules. The technology is based on custom-printed 3D hydrogels with delayed release characteristics. It will was at the 2nd annual 3d Printing and Beyond...